Does the use of polymer-free drug eluting stents improve clinical outcomes of patients undergoing percutaneous coronary interventions?

Itamar Loewenstein, Aviram Hochstadt, Ilan Merdler, Ehud Chorin, Atalia Wenkert, Yonatan Moshkovits, Jonathan Erez, Ella Toledano, Yaron Arbel, Amir Halkin, Jeremy Ben-Shoshan, Ariel Finkelstein, Shmuel Banai, Maayan Konigstein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background Implantation of drug eluting stents (DES) is the mainstay treatment for patients requiring percutaneous coronary intervention (PCI). The polymer coating of DES has been associated with inflammatory response, increased arterial injury and long-term in-stent restenosis and thrombosis. Polymer-free stents (PFS) were designed to overcome limitations of polymer-coated stents (PCS). Our aim was to compare clinical outcomes of patients undergoing PCI with PFS versus contemporary PCS. Methods This is a prospective, open-label registry study enrolling consecutive all-comers patients admitted to a single center and undergoing PCI using contemporary DES. Clinical outcomes were compared between patients treated with PFS and PCS. The primary endpoint was target lesion revascularization (TLR) at 12 months. Subgroup analyses were conducted for diabetic and nondiabetic patients. Results Overall, 1664 patients were included: 928 (55.8%) of which were treated with PFS and 736 (44.2%) with PCS for 2046 and 1462 lesions, respectively. At 12 months, TLR rates were not significantly different between the groups (1.7% vs. 2.3% for PFS and PCS, respectively, P = 0.48). The use of PFS did not improve clinical outcomes among diabetic patients in comparison with PCS. Target vessel revascularization and major adverse cardiac events rates were also similar between groups, regardless of diabetes status. Conclusion Newer generation DES offer excellent results in diabetic and nondiabetic patients without significant differences in outcomes between PCS and PFS.

Original languageEnglish
Pages (from-to)354-361
Number of pages8
JournalCoronary Artery Disease
Issue number5
StatePublished - 1 Aug 2022


  • acute coronary syndrome
  • drug eluting stents
  • polymer-coated stents
  • polymer-free stents


Dive into the research topics of 'Does the use of polymer-free drug eluting stents improve clinical outcomes of patients undergoing percutaneous coronary interventions?'. Together they form a unique fingerprint.

Cite this